CellSource Co., Ltd. (TSE: 4880)
Health Care · Life Sciences Tools & Services · JP
¥337.00
-5.34% today · -46.2% 1Y
CellSource Co., Ltd. (TSE: 4880) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $42.05M and employs 148 people.
Over the last twelve months the share price has lost 46.2%, trading between 294.00 and 654.00.
Tweenvest scores CellSource Co., Ltd. across four factors: quality 73/100, value 63/100, dividend 20/100. Its strongest factor is quality.
4880 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.05M
- Revenue (TTM)
- $23.39M
- P/E
- 95.44
- EPS
- 3.53
- Dividend yield
- 1.40%
- Beta (5Y)
- -0.11
- 52-week high
- ¥654.00
- 52-week low
- ¥294.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.85M
- Employees
- 148
- Next earnings
- —
About CellSource Co., Ltd.
CellSource Co., Ltd. operates within both the regenerative medicine and consumer product sectors. Among its offerings is Signalift, an anti-aging solution. The company, which was established in 2015, is headquartered in Tokyo, Japan.
- ISIN
- JP3423580004
- Founded
- 2015
- Listed since
- Oct 29, 2019
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.47B | $627.79 | -0.15% |
| Danaher CorporationNYSE: DHR | $151.22B | $215.43 | +0.15% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $69.06B | CN¥155.84 | -4.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.21B | CHF593.80 | +1.02% |
| Agilent Technologies, Inc.NYSE: A | $43.33B | $154.69 | +0.82% |
| IQVIA Holdings Inc.NYSE: IQV | $42.84B | $259.37 | -0.33% |
| Waters CorporationNYSE: WAT | $40.36B | $414.44 | +0.90% |
Figures last refreshed Aug 18, 2026.